Showing posts with label Counterfeit pharmaceuticals. Show all posts
Showing posts with label Counterfeit pharmaceuticals. Show all posts
Saturday, March 17, 2012
Caveat Oncologist: Clinical Findings and Consequences of Distributing Counterfeit Erythropoietin in the United States (Florida)
Caveat Oncologist: Clinical Findings and Consequences of Distributing Counterfeit Erythropoietin in the United States [Original Contributions]:
Purpose:
Counterfeit pharmaceuticals pose risks domestically. Because of their cost, cancer pharmaceuticals are vulnerable. We review findings from a domestic counterfeiting episode involving erythropoietin and outline anticounterfeiting recommendations for policy makers, patients, and health care professionals.
Subscribe to:
Posts
(
Atom
)
